Detalhe da pesquisa
1.
Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia.
Br J Haematol
; 198(4): 684-692, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567407
2.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122325
3.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol
; 181(6): 782-790, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741758
4.
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Blood
; 127(24): 3082-91, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020088
5.
Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.
Genes Chromosomes Cancer
; 55(1): 16-24, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26391112
6.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant
; 21(8): 1437-44, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865648
7.
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
Biol Blood Marrow Transplant
; 20(11): 1813-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042735
8.
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada.
Leuk Lymphoma
; 64(6): 1129-1138, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086469
9.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol
; 158(2): 174-185, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22640008
10.
Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada.
Leuk Res
; 103: 106538, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647819
11.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(5): 639-46, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20005967
12.
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
Blood
; 112(12): 4639-45, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723428
13.
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma.
Blood Adv
; 4(15): 3486-3494, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735654
14.
Ultrasensitive Detection of NOTCH1 c.7544_7545delCT Mutations in Chronic Lymphocytic Leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts Clinical Outcome in Cases with Trisomy 12.
J Mol Diagn
; 22(4): 571-578, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036086
15.
Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
Leuk Res
; 91: 106335, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32114372
16.
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Nat Commun
; 11(1): 1044, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32098966
17.
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biol Blood Marrow Transplant
; 15(2): 205-13, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167680
18.
Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
Leuk Res
; 84: 106193, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325731
19.
Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.
Leuk Lymphoma
; 59(6): 1356-1363, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032719
20.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Clin Lymphoma Myeloma Leuk
; 18(11): e481-e491, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100330